l-carnitine heart arrhythmia Revisiting the Role of Carnitine in Disease Through the Lens of the Gut Microbiota Comprehensive review of the expanding

Healthcare providers give propionyl-L-carnitine intravenously (by IV) for treating PVD and intermittent claudication

Putting xanthine oxidoreductase and aldehyde oxidase on the NO metabolism map: Nitrite reduction by molybdoenzymes

In a number of disease states, diffuse fibrosis can be assessed by quantitative CMR relaxometry, incorporating T 1 mapping with high reproducibility, however it was not possible in the present study to include T 1 mapping sequences

Restoration of IPA or BHB attenuates inflammation and barrier defects, outlining a microbiotametabolitestem cell axis that could be therapeutically targeted in inflammatory bowel disease and other barrier disorders